Breakout Session IV

Breakout Session Options:

  • Hot Topic: Breakdown The Barriers Of Biases
  • Hot Topic: Inclusive Horizons: Leveraging Data & Technology For DEI Recruitment
  • Ideas To Action: Non-Profits: Brokers Of Trust For Inclusive Trials
  • Solution Studio: Craft Your Site’s DEI Strategy
  • Inclusivity Forum: People With Disabilities


Hot Topic: Breakdown The Barriers Of Biases

As we strive for greater inclusivity in clinical research, it is essential to recognize and dismantle implicit biases that may hinder inclusive enrollment. This session not only raises awareness about internal biases but equips participants with practical strategies and tools to foster inclusivity and diversity their workforce. By confronting these challenges head-on, we pave the way for stronger, more impactful research that benefits historically marginalized populations and enhances clinical research outcomes.

Miaesha Campbell
, Sr. Director, Patient Recruitment, Medpace

Leia Cruz,
Clinical Program Director, Genentech
Rachael Fones,
Director, Government & Public Affairs, IQVIA
LaToya Hinton, MPH,
CEO/Research Director,Next Innovative Clinical Research
Michelle Whyte-Purnell, RN, Site  Partnership Manager Team Lead, Operational Feasibility Lead, Sanofi


Hot Topic: Inclusive Horizons: Leveraging Data and Technology for DEI Recruitment

This session will dive deep into the revolutionary ways data and technology can be harnessed to overcome barriers and foster inclusivity in patient recruitment for clinical trials. Explore how data analytics and artificial intelligence are revolutionizing the identification and engagement of various patient populations. We’ll also discuss privacy, informed consent, and the responsible use of patient information to ensure trust and compliance.

T.J. Sharpe
, Patient Engagement Program Manager, Medidata Solutions

Nicholas Focil,
CEO, FOMAT Clinical Research
Katie Shaw,
Senior Director, Global Patient & Site Solutions , IQVIA
Brittany Gerald,
Sr. Manager, Clinical Trial Diversity and Inclusion, Patient and Site, Moderma


Ideas to Action: Non-Profits: Brokers Of Trust For Inclusive Trials

Examine the critical role of non-profit organizations in fostering DEI within clinical trials through the strategic concept of trust brokerage. This session will spotlight how non-profits serve as essential bridges connecting research sites, companies, and diverse communities. By intentionally involving individuals who already possess the community’s trust, we can amplify collaboration and inclusivity in research to advance treatment options for all.

Yvette Mingo, Director, Emerson Diversity Health Foundation 

Ammy Astacio, MD, MPH, Director of Community Health Worker Initiative, Fulton DeKalb Authority (FDHA)
Zoé Felicié,
Sr. Patient Diversity Specialist, PPD, part of Thermo Fisher Scientific
Fabian Sandoval, MD, President and CEO, Emerson Clinical Research Institute


Solutions Studio: Craft Your Site’s DEI Strategy

Many research sites find themselves in uncharted territory when it comes to crafting a diversity plan. This session will bridge that gap by offering a step-by-step guide and template for site-level diversity planning. Learn where to begin, what crucial elements to include, and gain clarity on the overall structure. Our expert speakers will guide you through the process of creating both short and long-term strategic blueprints, equipping you with practical tools to implement immediately at your site.

Kim Ribeiro, MS,
Head, Diversity & Patient Inclusion, AbbVie

Maria Graber, MD, CPI, CCRP, QM-IAOCR, CEO, AGA Clinical Trials
Shanna Nixon,
Director, Site Solutions, Head of Americas, Parexel
Tolulope Olabintan, MD,
Family Medicine Physician and Principal Investigator, Prime Clinical Research


Inclusivity Forum: People with Disabilities

This is not just a breakout session; it’s a gathering to collaboratively discuss solutions and best practices, confront challenges, and uncover opportunities to foster a more inclusive clinical research environment. In this open forum, we’ll focus on the multifaceted aspects of inclusive, diverse, and equitable clinical trials for persons with disabilities. Come together to share, learn, and collectively work towards building more representative and equitable clinical research experiences and outcomes.

David Vulcano, LCSW, MBA, CIP, RAC, Honorary President, Vice President, Clinical Research Compliance & Integrity, SCRS, HCA Healthcare

Savine DaCosta, MBA, Health Equity Lead, Biogen
Willyanne DeCormier Plosky, DrPH,
Program Director, Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard
Stacy Hurt, MHA, MBA, Chief Patient Officer, Parexel
Cecile Gonzales- Cerimele, Sr. Director Diversity & Inclusion in Clinical Trials, Lilly


Location: See App for Room Location Date: April 9, 2024 Time: 10:30 - 11:30